ARDSLEY ADVISORY PARTNERS LP - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 26 filers reported holding SEELOS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARDSLEY ADVISORY PARTNERS LP ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$75,000
-7.4%
80,0000.0%0.01%
-17.6%
Q2 2020$81,000
+138.2%
80,000
+14.3%
0.02%
+30.8%
Q1 2020$34,000
-49.3%
70,000
+40.0%
0.01%
+18.2%
Q4 2019$67,000
+45.7%
50,0000.0%0.01%
+10.0%
Q3 2019$46,000
-58.2%
50,0000.0%0.01%
-41.2%
Q2 2019$110,000
-17.9%
50,000
+25.0%
0.02%
-34.6%
Q1 2019$134,00040,0000.03%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 2,033,020$1,904,0000.13%
1492 Capital Management LLC 150,000$141,0000.11%
Spark Investment Management LLC 13,100$12,0000.02%
ARDSLEY ADVISORY PARTNERS LP 80,000$75,0000.01%
GSA CAPITAL PARTNERS LLP 27,437$26,0000.00%
WealthPLAN Partners, LLC 20,000$18,0000.00%
CIBC WORLD MARKET INC. 500,000$468,0000.00%
CAPITAL COUNSEL LLC/NY 10,000$9,0000.00%
J.W. COLE ADVISORS, INC. 10,000$9,0000.00%
Renaissance Technologies 591,086$554,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders